Atropine sulfate monohydrate has been evaluated across numerous clinical trials spanning Early Phase I through Phase IV, alongside non-interventional studies. Sponsored by academic medical centers, specialized eye foundations, and healthcare companies, these studies focus on ophthalmic disorders such as pediatric myopia progression and amblyopia, as well as systemic indications including anesthesia premedication and organophosphorus poisoning management. Globally, these investigations encompass active, recruiting, completed, terminated, and withdrawn recruitment statuses.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05667454 | RECRUITING | Progressive Myopia |
Erasmus Medical Center |
2022-12-19 | PHASE3 |
| NCT06765603 | NOT_YET_RECRUITING | Myopia |
Singapore National Eye Centre |
2025-02-01 | PHASE2 |
| NCT07095894 | RECRUITING | Myopia |
Jaeb Center for Health Research |
2026-06-01 | PHASE3 |
| NCT07567040 | RECRUITING | Myopia |
Ohio State University |
2026-05-27 | PHASE3 |
| NCT07434635 | RECRUITING | Eye Disorders |
University of California, San Francisco |
2026-03-10 | PHASE4 |
| NCT05815784 | ACTIVE_NOT_RECRUITING | Myopia |
Ann & Robert H Lurie Children's Hospital of Chicago |
2023-05-02 | PHASE2 |
| NCT07028827 | RECRUITING | Myopia |
Ocus Innovation Ireland Limited |
2025-09-01 | PHASE3 |
| NCT07271875 | NOT_YET_RECRUITING | Postoperative Gastrointestinal Dysfunction (POGD); Postoperative Ileus; Colorectal Surgery |
Xijing Hospital |
2026-01-01 | PHASE3 |
| NCT06389110 | RECRUITING | Myopia; Myopia, Progressive |
Laboratorios Sophia S.A de C.V. |
2025-03-15 | PHASE3 |
| NCT07164092 | NOT_YET_RECRUITING | Myopia |
Mansoura University |
2025-09 | PHASE2; PHASE3 |
| NCT07329777 | RECRUITING | Myopia Progression |
IDB VisionCare SDN BHD |
2025-09-17 | PHASE3 |
| NCT07756359 | NOT_YET_RECRUITING | Pouch, Ileal; Pouches, Ileoanal; Bowel Diseases, Inflammatory |
University of North Carolina, Chapel Hill |
2026-09 | PHASE4 |
| NCT07364370 | NOT_YET_RECRUITING | Pediatric Cataract; IOL Implantation; Myopia Progression |
Cairo University |
2026-02 | |
| NCT07475585 | NOT_YET_RECRUITING | Myopia; Ear Acupressure Pellets; Hyperopia Reserve; Low-concentration Atropine Eye Drops; Eye Axis |
Fangbiao Tao |
2026-03-30 | |
| NCT07449247 | NOT_YET_RECRUITING | Pre-myopia |
Tianjin Medical University Eye Hospital |
2026-03-30 | PHASE1; PHASE2 |
| NCT07129889 | NOT_YET_RECRUITING | Myopia |
Ningbo Eye Hospital |
2025-12-02 | |
| NCT07176949 | RECRUITING | Myopia; Pre-myopia |
Shanghai Eye Disease Prevention and Treatment Center |
2025-06-01 | |
| NCT07367178 | NOT_YET_RECRUITING | Breast Cancer; Advanced HR+/HER2- Breast Cancer; Advanced Triple-Negative Breast Cancer |
MedSIR |
2026-07 | PHASE2 |
| NCT06912048 | RECRUITING | Autonomic Function |
University of Ulm |
2025-05-14 | |
| NCT04770610 | ACTIVE_NOT_RECRUITING | Myopia, Progressive |
Ocumension (Hong Kong) Limited |
2021-04-01 | PHASE3 |
| NCT05379855 | RECRUITING | Exotropia; Exophoria; Myopia |
Eye & ENT Hospital of Fudan University |
2024-03-02 | |
| NCT06824025 | RECRUITING | Post-Dural Puncture Headache |
Minia University |
2025-02-20 | EARLY_PHASE1 |
| NCT06667037 | ACTIVE_NOT_RECRUITING | Myopia |
Zhongshan Ophthalmic Center, Sun Yat-sen University |
2024-09-21 | |
| NCT07724210 | NOT_YET_RECRUITING | Myopia; Prevention and Control |
Beijing Tongren Hospital |
2026-08-20 | |
| NCT06708156 | RECRUITING | Myopia; Myopia Progression |
Oupushifang Pharmaceutical Technology Co., Ltd. |
2024-06-15 | PHASE3 |
| NCT07537166 | ENROLLING_BY_INVITATION | Acupressure |
China Medical University Hospital |
2026-04-11 | |
| NCT06579287 | ACTIVE_NOT_RECRUITING | Myopia, Progressive |
Sunhawk Vision Biotech, Inc. |
2025-01-22 | PHASE2 |
| NCT06282848 | RECRUITING | Myopia |
The Hong Kong Polytechnic University |
2024-01-01 | |
| NCT07777835 | RECRUITING | Organophosphate Poisoning |
Muhammad Aamir Latif |
2026-05-10 | |
| NCT04641702 | RECRUITING | Achalasia |
Emory University |
2021-03-17 | PHASE4 |
| NCT00992901 | RECRUITING | Post Bariatricsurgery; Hypoglycemia |
The University of Texas Health Science Center at San Antonio |
2009-10 | EARLY_PHASE1 |
| NCT02823665 | RECRUITING | Post Bariatric Surgery; Gastric Bypass; Sleeve Gastrectomy; Hypoglycemia After Gastric Bypass |
The University of Texas Health Science Center at San Antonio |
2015-07 | EARLY_PHASE1 |
| NCT05331664 | RECRUITING | Rhegmatogenous Retinal Detachment |
Massachusetts Eye and Ear Infirmary |
2022-07-25 | PHASE4 |
| NCT07666984 | RECRUITING | Neuromuscular Blockade Reversal Agent |
Cukurova University |
2026-06-04 | PHASE4 |
| NCT07676981 | RECRUITING | Epiphora |
Rehan Ahmed |
2026-06 | PHASE2 |
| NCT06200194 | ACTIVE_NOT_RECRUITING | Myopia; Preschool |
National Yang Ming Chiao Tung University Hospital |
2024-10-06 | PHASE2 |
| NCT06450132 | ACTIVE_NOT_RECRUITING | Myopia |
Ohio State University |
2024-08-01 | PHASE4 |
| NCT06358755 | ACTIVE_NOT_RECRUITING | Myopia |
The Hong Kong Polytechnic University |
2024-07-12 | |
| NCT07626892 | COMPLETED | Myopia Progression; Atropine |
Khyber Medical College, Peshawar |
2024-06-03 | PHASE3 |
| NCT07614113 | COMPLETED | Myopia; Progressive Myopia; Refractive Errors |
University of Faisalabad |
2025-02-17 | |
| NCT07456488 | RECRUITING | Focus on Axial Length |
Liaquat National Hospital & Medical College |
2025-07-13 | PHASE2 |
| NCT06523504 | RECRUITING | Myopia |
Ruihua Wei |
2024-02-01 | PHASE1; PHASE2 |
| NCT04923841 | COMPLETED | Myopia |
The Hong Kong Polytechnic University |
2021-09-09 | |
| NCT05065424 | COMPLETED | Respiratory Distress Syndrome, Newborn |
University of Texas Southwestern Medical Center |
2022-04-06 | PHASE4 |
| NCT07519226 | COMPLETED | Shock |
Lihua Wen |
2024-05-08 | |
| NCT07268586 | COMPLETED | Myocardial Infarction |
Ain Shams University |
2025-08-01 | PHASE4 |
| NCT05062031 | COMPLETED | Myopia |
Fondation Ophtalmologique Adolphe de Rothschild |
2021-10-19 | |
| NCT07253428 | ACTIVE_NOT_RECRUITING | Emergence Agitation; Nasal Surgery |
Ain Shams University |
2025-10-30 | |
| NCT05803863 | UNKNOWN | Myopia |
University of Medicine and Pharmacy at Ho Chi Minh City |
2023-04-15 | PHASE4 |
| NCT06265454 | UNKNOWN | Myopia Progression; Axial Length, Eye; Sclera Thickness |
Ain Shams University |
2024-09-01 | PHASE2 |
| NCT06922097 | COMPLETED | Intraoperative Bradycardia |
University of Hamburg-Eppendorf |
2025-04-07 | |
| NCT06034379 | RECRUITING | Myopia |
Kubota Vision Inc. |
2023-10-01 | |
| NCT07406399 | COMPLETED | High Myopia; Low Concentration Atropine; Soft Contact Lens; Children |
Beijing Tongren Hospital |
2023-06-30 | PHASE4 |
| NCT06729047 | NOT_YET_RECRUITING | Post-Dural Puncture Headache |
Assiut University |
2024-12-15 | PHASE1; PHASE2 |
| NCT03865160 | ACTIVE_NOT_RECRUITING | Myopia, Progressive |
University Eye Hospital, Freiburg |
2021-10-19 | PHASE2; PHASE3 |
| NCT06082388 | UNKNOWN | Cardiac Arrhythmia; Supraventricular Arrhythmia |
Medical University of Lodz |
2023-11-09 | |
| NCT07092046 | COMPLETED | Minimal Flow Anesthesia; General Anaesthesia; Inhalation Anesthesia; Infection Risk; Anesthesia Circuit; Microbial Colonization; Anesthesia Equipment Bacterial Contamination |
Ankara City Hospital Bilkent |
2025-08-01 | |
| NCT02858310 | COMPLETED | Papillomavirus Infections; Cervical Intraepithelial Neoplasia; Carcinoma In Situ; Vulvar Neoplasms; Vulvar Diseases |
National Cancer Institute (NCI) |
2017-01-27 | PHASE1; PHASE2 |
| NCT06865677 | TERMINATED | Recurrent Platinum Resistant Epithelial Ovarian Carcinoma; Recurrent Epithelial Endometrial Carcinoma; Recurrent Epithelial Cervical Carcinoma |
National Cancer Institute (NCI) |
2025-06-09 | PHASE2 |
| NCT02078336 | UNKNOWN | Dental Care for Disabled |
Universitaire Ziekenhuizen KU Leuven |
2013-12 | PHASE4 |
| NCT06431841 | ACTIVE_NOT_RECRUITING | Myopia |
Hospital San Carlos, Madrid |
2022-02-23 | PHASE4 |
| NCT06034366 | UNKNOWN | Myopia |
He Eye Hospital |
2023-10-01 | |
| NCT06209320 | ACTIVE_NOT_RECRUITING | Myopia |
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
2022-03-15 | PHASE3 |
| NCT05560542 | COMPLETED | Morphine Adverse Reaction |
Assiut University |
2022-10-01 | |
| NCT06794450 | RECRUITING | Neuromuscular Blocking Agents; Reversal of Neuromuscular Blockade; Recovery Time |
Universitas Padjadjaran |
2024-11-05 | PHASE1; PHASE2 |
| NCT06493838 | UNKNOWN | Acute Pain |
Minia University |
2024-07-15 | PHASE4 |
| NCT04393103 | WITHDRAWN | Organophosphorus Poisoning |
Amani Hassan Abdel-Wahab |
2024-04-01 | PHASE2; PHASE3 |
| NCT03140358 | ACTIVE_NOT_RECRUITING | Myopia |
Singapore National Eye Centre |
2017-04-21 | PHASE3 |
| NCT05597163 | UNKNOWN | Myopia, Progressive |
Shanghai Eye Disease Prevention and Treatment Center |
2023-01-15 | |
| NCT03942419 | TERMINATED | Myopia |
Eyenovia Inc. |
2019-06-03 | PHASE3 |
| NCT06029530 | WITHDRAWN | Myopia |
Ohio State University |
2024-01-01 | PHASE1 |
| NCT04699357 | COMPLETED | High Myopia |
Shanghai Eye Disease Prevention and Treatment Center |
2021-07-04 | |
| NCT06327399 | COMPLETED | Dexmedetomidine; Intubation Complication |
Kasr El Aini Hospital |
2024-04-01 | PHASE2 |
| NCT06344429 | UNKNOWN | Myopia |
Essilor-Polylite Taiwan Co., Ltd. |
2023-08-20 | |
| NCT05203432 | UNKNOWN | Myopia |
Shanghai Eye Disease Prevention and Treatment Center |
2022-02-10 | |
| NCT06174935 | UNKNOWN | Vitreous Floaters |
Jeanette Du |
2024-01-01 | PHASE2 |
| NCT06210165 | UNKNOWN | Atelectasis, Postoperative; Pulmonary Function; Newborn, Abnormal |
Rhendra Hardy Mohamad Zaini |
2022-12-07 | |
| NCT04173780 | TERMINATED | Myopia Progressing; Childhood |
University Hospital, Strasbourg, France |
2020-02-12 | PHASE2; PHASE3 |
| NCT06366087 | COMPLETED | Atropine Bioequivalence |
Biomedical Advanced Research and Development Authority |
2024-04-15 | PHASE1 |
| NCT03911271 | COMPLETED | Myopia |
Line Kessel |
2019-05-30 | PHASE2 |
| NCT06291363 | Not yet recruiting | Opioid Use Unspecified|Anesthesia|Nociceptive Pain |
Ciusss de L''Est de l''Île de Montréal |
2024-04-04 | Phase 4 |
| NCT05939882 | UNKNOWN | Myopia, Progressive |
Shanghai Eye Disease Prevention and Treatment Center |
2023-04-01 | |
| NCT06263946 | Recruiting | Myopia |
Essilor International |
2024-03-22 | Not Applicable |
| NCT03690089 | ACTIVE_NOT_RECRUITING | Myopia |
Belfast Health and Social Care Trust |
2019-04-03 | PHASE2 |
| NCT05666219 | WITHDRAWN | Complete Heart Block; Inferior Wall Myocardial Infarction |
National Institute of Cardiovascular Diseases, Pakistan |
2022-12-19 | PHASE4 |
| NCT06071260 | UNKNOWN | Myopia, Progressive |
He Eye Hospital |
2023-12-01 | |
| NCT05448989 | UNKNOWN | Myopia |
Shanghai Eye Disease Prevention and Treatment Center |
2022-01-01 | PHASE4 |
| NCT05892913 | COMPLETED | Pregnancy; Cesarean Section; Anesthesia, Spinal |
Abant Izzet Baysal University |
2023-07-19 | PHASE4 |
| NCT06697522 | COMPLETED | Myopia |
Ocumension Therapeutics (Suzhou) Co., Ltd |
2023-06-25 | PHASE3 |
| NCT03030417 | COMPLETED | Solid Tumors; Lymphoma |
National Cancer Institute (NCI) |
2017-02-27 | PHASE1 |
| NCT06111352 | COMPLETED | Organophosphorus Poisoning |
Sir Salimullah Medical College Mitford Hospital |
2022-06-01 | PHASE2 |
| NCT04391361 | UNKNOWN | Amyotrophic Lateral Sclerosis; Respiratory Function; Scopolamine |
Ruijin Hospital |
2020-11-01 | PHASE2 |
| NCT03909165 | COMPLETED | Neuromuscular Blockade |
Merck Sharp & Dohme LLC |
2019-07-23 | PHASE4 |
| NCT06727019 | COMPLETED | Myopia |
Beijing Tongren Hospital |
2023-04-10 | |
| NCT05478356 | UNKNOWN | Myopia |
Evidence Based Cataract Study Group |
2022-08-01 | |
| NCT06209281 | ACTIVE_NOT_RECRUITING | Myopia |
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. |
2022-05-13 | PHASE3 |
| NCT05357326 | UNKNOWN | Myopia |
Shanghai Eye Disease Prevention and Treatment Center |
2021-07-01 | PHASE4 |
| NCT05164367 | COMPLETED | Cerebral Palsy; Sialorrhea |
University of Utah |
2022-10-01 | EARLY_PHASE1 |
| NCT05529056 | UNKNOWN | Myopia; Children |
LitePharmTech Co., Ltd. |
2022-05-25 | PHASE3 |
| NCT05855018 | UNKNOWN | Pharmacokinetics |
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited |
2023-05-09 | PHASE1 |
| NCT05006638 | UNKNOWN | Pesticide Poisoning |
Aya Sabry Mohamed Mohamed |
2022-12 | PHASE4 |
| NCT05658380 | COMPLETED | Anesthesia |
Ain Shams University |
2022-12-25 | PHASE3 |
| NCT05481489 | WITHDRAWN | Myopia |
Laboratorios Sophia S.A de C.V. |
2023-02-01 | PHASE1 |
| NCT05449015 | UNKNOWN | Accomodation; Refractive Errors; Myopia; Cycloplegia |
Shanghai Eye Disease Prevention and Treatment Center |
2020-12-22 | PHASE4 |
| NCT05372991 | COMPLETED | Myopia, Progressive |
Cloudbreak Therapeutics, LLC |
2022-07-20 | PHASE1; PHASE2 |
| NCT05470881 | COMPLETED | Myopia |
Laboratorios Sophia S.A de C.V. |
2022-08-20 | PHASE1 |
| NCT03094052 | COMPLETED | HER2-positive Breast Cancer; Breast Adenocarcinoma; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7 |
University of California, San Francisco |
2018-10-09 | PHASE2 |
| NCT07674966 | COMPLETED | Myopia |
University of California, Berkeley |
2022-03-16 | PHASE1 |
| NCT06266962 | COMPLETED | Intraoperative Floppy Iris Syndrome; Cataract; Age-related Cataract; Adrenergic Receptor Antagonist Adverse Reaction |
University Hospital Olomouc |
2020-07-01 | PHASE4 |
| NCT05199597 | COMPLETED | Myopia |
Ohio State University |
2022-05-19 | EARLY_PHASE1 |
| NCT05137288 | UNKNOWN | Perineal Surgery |
Sohag University |
2021-12-01 | |
| NCT03334253 | COMPLETED | Myopia |
Jaeb Center for Health Research |
2018-06-01 | PHASE3 |
| NCT03508817 | UNKNOWN | Myopia, Progressive |
Sultan Qaboos University |
2018-12-20 | EARLY_PHASE1 |
| NCT03754153 | COMPLETED | Amblyopia |
Moorfields Eye Hospital NHS Foundation Trust |
2019-10-28 | |
| NCT04777383 | TERMINATED | Cardiovascular Diseases; Vascular Diseases |
University Hospital, Linkoeping |
2019-04-01 | |
| NCT04910477 | COMPLETED | Postdural Puncture Headache |
Assiut University |
2021-06-01 | PHASE3 |
| NCT04625088 | COMPLETED | Healthy |
SciMar Ltd. |
2021-03-01 | |
| NCT04338373 | UNKNOWN | Myopia |
The V.P. Vyhodcev Eye Hospital |
2020-02-17 | PHASE3 |
| NCT03972683 | WITHDRAWN | Vasoconstriction; Vasodilation |
Colorado State University |
2019-04-16 | EARLY_PHASE1 |
| NCT03949101 | UNKNOWN | Myopia |
Shanghai Eye Disease Prevention and Treatment Center |
2019-05-08 | PHASE4 |
| NCT02955927 | COMPLETED | Myopia |
The Hong Kong Polytechnic University |
2016-11 | |
| NCT00748059 | COMPLETED | Autonomic Nervous System Diseases; Orthostatic Hypotension; Dopamine Beta-Hydroxylase Deficiency; Orthostatic Intolerance |
Vanderbilt University Medical Center |
1996-12 | PHASE1 |
| NCT03984526 | COMPLETED | Anesthesia, Spinal; Dexmedetomidine; Bradycardia |
Ajou University School of Medicine |
2019-06-25 | PHASE4 |
| NCT03312257 | COMPLETED | Refractive Errors |
Jenny Jones |
2016-07 | |
| NCT06609993 | COMPLETED | Aortic Aneurysm; Postoperative Nausea and Vomiting; Postoperative Pain; Haemodynamic Stability |
Michał Stasiowski |
2017-12-12 | |
| NCT04505228 | COMPLETED | Hypertensive Heart Disease |
Jun Xiao |
2020-01-20 | |
| NCT04290039 | COMPLETED | Toxic Effect of Organophosphate and Carbamate Insecticides |
Biomedical Advanced Research and Development Authority |
2020-01-04 | PHASE1 |
| NCT03351608 | COMPLETED | Neuromuscular Blockade |
Merck Sharp & Dohme LLC |
2018-02-12 | PHASE4 |
| NCT03997006 | COMPLETED | Post-Dural Puncture Headache |
Damanhour Teaching Hospital |
2019-01-01 | PHASE4 |
| NCT03374306 | COMPLETED | Myopia |
The Hong Kong Polytechnic University |
2018-02-01 | |
| NCT03144453 | UNKNOWN | Anesthesiology Management |
Regina Elena Cancer Institute |
2017-05-02 | PHASE4 |
| NCT02870478 | COMPLETED | Myopia |
University of California, Berkeley |
2016-07 | PHASE3 |
| NCT02839668 | COMPLETED | Breast Cancer |
Iuliu Hatieganu University of Medicine and Pharmacy |
2016-08 | PHASE2 |
| NCT03932578 | COMPLETED | Nausea; Vomiting |
Mansoura University |
2019-05-05 | PHASE4 |
| NCT02743104 | SUSPENDED | Paediatric Flexible Bronchoscopy |
Rabin Medical Center |
2016-05 | |
| NCT03638726 | UNKNOWN | Cataract; Mydriasis; Adverse Drug Event |
Dar El Oyoun Hospital |
2018-09-28 | PHASE4 |
| NCT03544827 | COMPLETED | Myopia |
State University of New York College of Optometry |
2018-05-21 | PHASE4 |
| NCT03690414 | COMPLETED | Myopia |
Hai Yen Eye Care |
2018-10-01 | PHASE1 |
| NCT02927223 | COMPLETED | Catecholaminergic Polymorphic Ventricular Tachycardia |
Vanderbilt University |
2016-10 | |
| NCT03593044 | COMPLETED | Myopia |
Jeffrey J. Walline, OD PhD |
2018-07-23 | PHASE1; PHASE2 |
| NCT03580889 | UNKNOWN | Lower Extremity Fracture |
B.P. Koirala Institute of Health Sciences |
2017-09-15 | PHASE4 |
| NCT03322150 | TERMINATED | Spinal Anesthesia |
Yonsei University |
2017-10-01 | |
| NCT03322098 | COMPLETED | Spinal Anesthesia |
Yonsei University |
2017-10-16 | |
| NCT03699423 | COMPLETED | Myopia |
Hai Yen Eye Care |
2018-03-08 | PHASE1 |
| NCT03328312 | UNKNOWN | Incidence of Postoperative Residual Curarization |
Iuliu Hatieganu University of Medicine and Pharmacy |
2017-12-01 | EARLY_PHASE1 |
| NCT04612998 | COMPLETED | Obesity; Pregnancy Related; Cesarean Section Complications; Spinal Anaesthetic Poisoning of Undetermined Intent; Hypotension |
Ataturk University |
2017-02-01 | |
| NCT02455921 | COMPLETED | Anesthesia; Functional |
Attikon Hospital |
2015-06 | PHASE4 |
| NCT02726620 | COMPLETED | Hypotension |
Vanderbilt University Medical Center |
2017-01-05 | |
| NCT03158142 | COMPLETED | Myopia |
State University of New York College of Optometry |
2017-03-15 | PHASE4 |
| NCT02939430 | UNKNOWN | Blood Coagulation Tests ( INR, APTT) |
Mansoura University |
2016-11 | |
| NCT03387956 | COMPLETED | Postoperative Nausea |
Assiut University |
2017-03-20 | |
| NCT02130167 | COMPLETED | Myopia Progression |
Chang Gung Memorial Hospital |
2012-08 | |
| NCT02769325 | UNKNOWN | Laparoscopic Surgery; Gynecology |
Clinica Santa Maria |
2016-05 | PHASE4 |
| NCT02698969 | UNKNOWN | Post-operative Residual Curarization |
University of Florence |
2014-11 | PHASE4 |
| NCT02410590 | WITHDRAWN | Neuromuscular Blockade |
Merck Sharp & Dohme LLC |
2015-07 | PHASE4 |
| NCT01490580 | COMPLETED | Premedication; Endotracheal Intubation |
Centre Hospitalier Intercommunal Creteil |
2012-05 | PHASE2; PHASE3 |
| NCT02700893 | COMPLETED | Premedication; Endotracheal Intubation; Cerebral Hypoperfusion |
Centre Hospitalier Intercommunal Creteil |
2016-03 | PHASE2; PHASE3 |
| NCT02361060 | COMPLETED | Major Abdominal Surgery |
Enrique Alday Muñoz |
2015-02 | PHASE4 |
| NCT02622126 | COMPLETED | Coagulation Defect; Bleeding |
Assiut University |
2016-01 | PHASE2 |
| NCT02676011 | COMPLETED | Bradycardia |
Assiut University |
2016-02 | PHASE2 |
| NCT02445599 | COMPLETED | Pain; Inadequate or Impaired Respiratory Function |
University of Debrecen |
2014-04 | PHASE4 |
| NCT01845636 | COMPLETED | Mild Cognitive Impairment |
New York State Psychiatric Institute |
2012-08 | PHASE4 |
| NCT02327923 | COMPLETED | Gall Stone Disease |
B.P. Koirala Institute of Health Sciences |
2015-01 | PHASE4 |
| NCT02522858 | COMPLETED | Bradycardia |
Sira Bang |
2015-08 | PHASE4 |
| NCT03839888 | COMPLETED | Myopia, Left Eye |
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
2015-01-01 | |
| NCT01761552 | UNKNOWN | Neuromuscular Blockade |
Hadassah Medical Organization |
2013-08 | PHASE4 |
| NCT02704923 | COMPLETED | Ventilator-Associated Pneumonia |
Universidade de Passo Fundo |
2015-02 | PHASE2 |
| NCT02419352 | COMPLETED | Post Operative Cognitive Dysfunction |
Attikon Hospital |
2010-09 | |
| NCT02160548 | COMPLETED | Organophosphate Poisoning |
Sylhet M.A.G.Osmani Medical College |
2015-04 | PHASE3 |
| NCT07033442 | COMPLETED | Anaesthesia; Intraocular Pressure; Trendelenburg Position; Robot Assisted Laparoscopic Radical Prostatectomy; Total Intravenous Anesthesia; Inhalation Anesthesia |
Ataturk Training and Research Hospital |
2015-07-23 | |
| NCT01951729 | COMPLETED | Pre-diabetes |
Washington University School of Medicine |
2013-03-13 | PHASE1 |
| NCT02752308 | COMPLETED | Hypospadias |
Isfahan University of Medical Sciences |
2014-09 | PHASE2; PHASE3 |
| NCT02228473 | UNKNOWN | Catheter Site Discomfort; Complications; Anesthesia; Urinary Bladder Neoplasms |
Seoul National University Hospital |
2014-09 | |
| NCT02194088 | COMPLETED | Pain |
Brigham and Women's Hospital |
2014-04 | PHASE3 |
| NCT02215382 | COMPLETED | Intraocular Pressure Changes During Tracheal Extubation |
Ordu University |
2014-08 | PHASE4 |
| NCT02633579 | COMPLETED | Healthy |
Universitaire Ziekenhuizen KU Leuven |
2012-10 | |
| NCT01595399 | UNKNOWN | Bradycardia; Hypoxemia |
University of Manitoba |
2012-04 | PHASE4 |
| NCT02082054 | UNKNOWN | Rhinitis, Seasonal, Allergic |
Magna Pharmaceuticals, Inc. |
2014-03 | PHASE2 |
| NCT00944710 | COMPLETED | Amblyopia |
Jaeb Center for Health Research |
2009-08 | PHASE3 |
| NCT01871935 | UNKNOWN | Haemodynamic Fluctuations During Off-pump CABG. |
University Medical Center Groningen |
2013-06 | |
| NCT01819064 | COMPLETED | Bradycardia; Arrhythmias |
State University of New York at Buffalo |
2013-02 | PHASE4 |
| NCT02658721 | COMPLETED | Anesthesia |
Bagcilar Training and Research Hospital |
2013-01 | PHASE3 |
| NCT01871922 | COMPLETED | Anesthesia-induced Negative Hemodynamic Effects |
University Medical Center Groningen |
2012-10 | |
| NCT01539044 | COMPLETED | Underdosing of Skeletal Muscle Relaxants for Laparotomy; Reversal of Skeletal Muscle Relaxant |
Hospital Sultanah Aminah Johor Bahru |
2012-02 | PHASE4 |
| NCT02186132 | COMPLETED | Bradycardia; Neostigmine Adverse Reaction; Adverse Reaction to Belladonna or Atropine |
Mahidol University |
2012-03 | PHASE4 |
| NCT01534442 | UNKNOWN | The Focus of This Study is to Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration. |
University Hospital, Gentofte, Copenhagen |
2011-09 | |
| NCT02055378 | COMPLETED | Myopia |
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
2011-01 | |
| NCT01422304 | COMPLETED | Neuromuscular Blockade; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Coagulation; Antithrombotic Agents |
Merck Sharp & Dohme LLC |
2011-10-12 | PHASE3 |
| NCT00251602 | COMPLETED | Healthy |
National Institute on Aging (NIA) |
2003-03 | PHASE1 |
| NCT01427985 | COMPLETED | Newborn; Preterm; Intubation |
University of Ulm |
2011-06 | PHASE4 |
| NCT00894179 | TERMINATED | Coronary Artery Disease |
Henry Ford Health System |
2009-10 | |
| NCT01464489 | COMPLETED | Intubation; Difficult |
Gachon University Gil Medical Center |
2011-05 | |
| NCT01191398 | COMPLETED | Sialorrhea |
Craig J. Huang |
2010-06 | |
| NCT00998205 | COMPLETED | Diastolic Dysfunction |
University of Missouri-Columbia |
2008-06 | |
| NCT00834470 | COMPLETED | Conscious Sedation |
Seoul National University Hospital |
2008-08 | PHASE4 |
| NCT00991627 | COMPLETED | Pregnancy; Cesarean Section; Anesthesia,Spinal; Hypotension |
University of Parma |
2009-09 | PHASE4 |
| NCT00947596 | COMPLETED | Organophosphorus Poisoning |
MicroDose Defense Products L.L.C. |
2009-08 | PHASE1 |
| NCT00320892 | TERMINATED | Noise; Death |
Soroka University Medical Center |
2007-01 | |
| NCT01858090 | COMPLETED | Elective Caesarean Section Surgeries |
Baskent University |
2009-01 | PHASE3 |
| NCT00623207 | COMPLETED | Chest Pain |
HaEmek Medical Center, Israel |
2007-12 | PHASE3 |
| NCT00724932 | COMPLETED | Anesthesia, General |
Merck Sharp & Dohme LLC |
2008-07-16 | PHASE3 |
| NCT00506675 | TERMINATED | Amblyopia |
Jaeb Center for Health Research |
2007-10 | PHASE3 |
| NCT00689208 | COMPLETED | Insulin Resistance |
AstraZeneca |
2007-05 | EARLY_PHASE1 |
| NCT00121524 | COMPLETED | Cardiac Arrest |
Petter Andreas Steen |
2003-01 | PHASE2 |
| NCT00921102 | COMPLETED | Cesarean Section; Anesthesia,Spinal; Postoperative Nausea and Vomiting |
University of Parma |
2007-05 | PHASE4 |
| NCT00815048 | COMPLETED | Endotracheal Intubation |
King Saud University |
2006-01 | PHASE4 |
| NCT00315328 | COMPLETED | Amblyopia |
Jaeb Center for Health Research |
2005-08 | PHASE3 |
| NCT00315302 | COMPLETED | Amblyopia |
Jaeb Center for Health Research |
2005-02 | PHASE3 |
| NCT00583323 | COMPLETED | Lymphoma |
Mayo Clinic |
2003-02 | PHASE3 |
| NCT00000170 | COMPLETED | Amblyopia |
Jaeb Center for Health Research |
1999-04 | PHASE3 |
| NCT00431392 | COMPLETED | Regional Blood Flow; Ocular Physiology |
Medical University of Vienna |
2001-09 | PHASE2 |
| NCT00575523 | COMPLETED | Arrhythmia; Respiratory Arrest |
Medical University of Vienna |
2003-10 | PHASE4 |
| NCT00001864 | COMPLETED | Amblyopia; Anisometropia; Strabismus |
National Eye Institute (NEI) |
1999-05 | PHASE3 |
| NCT00328900 | UNKNOWN | Hemorrhoids; Fissure in Ano |
Rikshospitalet University Hospital |
2006-01 | |
| NCT00094692 | COMPLETED | Amblyopia |
Jaeb Center for Health Research |
2002-10 | PHASE3 |
| NCT00457717 | COMPLETED | Myopia |
China Medical University, China |
2005-07 | PHASE1 |
| NCT00468091 | COMPLETED | Digestive Physiology; Gastrointestinal Motility; Gastrointestinal Hormones; Glucagon-like Peptide 1; Exendin (9-39) |
Ludwig-Maximilians - University of Munich |
1999-02 | PHASE1 |
| NCT00541177 | UNKNOWN | Myopia |
Min-Sheng General Hospital |
2007-04 | PHASE4 |
| NCT00371124 | UNKNOWN | Myopia |
Singapore National Eye Centre |
2006-03 | PHASE2; PHASE3 |
| NCT00094614 | COMPLETED | Amblyopia |
Jaeb Center for Health Research |
2002-06 | PHASE4 |
(data from https://clinicaltrials.gov, updated on 2025-04-27)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Atropine sulfate monohydrate Solubility in DMSO
- Atropine sulfate monohydrate Stock Solution
- Atropine sulfate monohydrate Storage
- Atropine sulfate monohydrate Stability
- Atropine sulfate monohydrate Molecular Weight
- Atropine sulfate monohydrate SMILES
- Atropine sulfate monohydrate CAS Number
- Atropine sulfate monohydrate Chemical Structure (2D and 3D)
- Atropine sulfate monohydrate SDS|MSDS